Radiation InjuriesRadiation DosageRadiation, IonizingAntineoplastic AgentsDose-Response Relationship, RadiationRadiotherapyAntineoplastic Combined Chemotherapy ProtocolsRadiotherapy DosageCombined Modality TherapyRadiation ToleranceRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedRadiationRadiation OncologyRadiation ProtectionDose FractionationRadiotherapy, AdjuvantChemotherapy, AdjuvantNeoplasmsRadiation MonitoringRadiotherapy Planning, Computer-AssistedCisplatinTreatment OutcomeDoxorubicinBrachytherapyRadiation PneumonitisCell Line, TumorDrug Screening Assays, AntitumorRadiation-Sensitizing AgentsRadiosurgeryRadiometryNeoplasm Recurrence, LocalBreast NeoplasmsBrain NeoplasmsNeoplasms, Radiation-InducedNeoplasm StagingCranial IrradiationRadiation Injuries, ExperimentalRadiotherapy, Computer-AssistedGamma RaysApoptosisDrug Resistance, NeoplasmDisease-Free SurvivalHead and Neck NeoplasmsSurvival AnalysisRadiotherapy, Image-GuidedEtoposideLung NeoplasmsParticle AcceleratorsAntineoplastic Agents, PhytogenicSurvival RateCell SurvivalTime FactorsCosmic RadiationRadiotherapy, High-EnergyPaclitaxelRadiodermatitisPrognosisCarcinoma, Squamous CellAdenocarcinomaProstatic NeoplasmsAntibiotics, AntineoplasticRadiation-Protective AgentsOrgans at RiskChemoradiotherapyFollow-Up StudiesCyclophosphamideXenograft Model Antitumor AssaysDNA DamageMice, NudeBackground RadiationRetrospective StudiesTumor Cells, CulturedTumor BurdenTomography, X-Ray ComputedNeoadjuvant TherapyVinblastineDrug Delivery SystemsDacarbazineBleomycinCobalt RadioisotopesFluorouracilMastectomy, SegmentalUltraviolet RaysAntineoplastic Agents, AlkylatingCarcinoma, Non-Small-Cell LungAntimetabolites, AntineoplasticDrug Administration ScheduleDose-Response Relationship, DrugCarboplatinCamptothecinGlioblastomaActuarial AnalysisClinical Trials as TopicHodgkin DiseaseCell ProliferationRadiation EffectsRadiobiologyDrug CarriersMethotrexate